MPZ-, GDAP1-, and NEFL-Related Charcot-Marie-Tooth Disease with Diverse Clinical and Electrophysiological Phenotypes

키워드

참고문헌 (45)

1. Madrid R, "The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies", J Neurol Sci, 32, pp.91~122 (1977)
2. Cortese A, "Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease", Neurology, 94, pp.e51~e61 (2020)
3. Gonzaga-Jauregui C, "Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy", Cell Rep, 12, pp.1169~1183 (2015)
4. Rossor AM, "Clinical implications of genetic advances in Charcot-Marie-Tooth disease", Nat Rev Neurol, 9, pp.562~571 (2013)
5. Lemke G, "Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin", Cell, 40, pp.501~508 (1985)
6. De Jonghe P, "The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype", Brain, 122(Pt 2), pp.281~290 (1999)
7. Hayasaka K, "Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene", Nat Genet, 5, pp.31~34 (1993)
8. Kochański A, "Mutations in the Myelin Protein Zero result in a spectrum of Charcot-Marie-Tooth phenotypes", Acta Myol, 23, pp.6~9 (2004)
9. Mastaglia FL, "Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy", J Neurol Neurosurg Psychiatry, 67, pp.174~179 (1999)
10. Sanmaneechai O, "Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene", Brain, 138(Pt 11), pp.3180~3192 (2015)
11. Senderek J, "Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations : two novel amino acid substitutions(Asp61Gly; Tyr119Cys)and a possible"hotspot"on Thr124Met", Brain Pathol, 10, pp.235~248 (2000)
12. Hattori N, "Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients", Brain, 126(Pt 1), pp.134~151 (2003)
13. Shy ME, "Phenotypic clustering in MPZ mutations", Brain, 127(Pt 2), pp.371~384 (2004)
14. Mazzeo A, "Charcot-Marie-Tooth disease type 1B : marked phenotypic variation of the Ser78Leu mutation in five Italian families", Acta Neurol Scand, 118, pp.328~332 (2008)
15. Senderek J, "Phenotypic variation of a novel nonsense mutation in the P0 intracellular domain", J Neurol Sci, 192, pp.49~51 (2001)
16. Estela A, "Charcot-Marie-Tooth-related gene GDAP1 complements cell cycle delay at G2", M phase in Saccharomyces cerevisiae fis1 gene-defective cells, 2011, pp.286, 36777~36786
17. Baxter RV, "Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A", 8q21, 2002, pp.30, 21~22
18. Cuesta A, "The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease", Nat Genet, 30, pp.22~25 (2002)
19. Claramunt R, "Genetics of Charcot-Marie-Tooth disease type 4A : mutations, inheritance, phenotypic variability, and founder effect", J Med Genet, 42, pp.358~365 (2005)
20. Senderek J, "Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy", Brain, 126(Pt 3), pp.642~649 (2003)
21. Mersiyanova IV, "A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene", Am J Hum Genet, 67, pp.37~46 (2000)
22. Jordanova A, "Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease", Brain, 126(Pt 3), pp.590~597 (2003)
23. Abe A, "Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease : nonsense mutation probably causes a recessive phenotype", J Hum Genet, 54, pp.94~97 (2009)
24. Yum SW, "A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy", Ann Neurol, 66, pp.759~770 (2009)
25. Berciano J, "NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype", J Neurol, 262, pp.1289~1300 (2015)
26. Hsu YH, "Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan", Ann Clin Transl Neurol, 6, pp.1090~1101 (2019)
27. Murphy SM, "Charcot-Marie-Tooth disease : frequency of genetic subtypes and guidelines for genetic testing", J Neurol Neurosurg Psychiatry, 83, pp.706~710 (2012)
28. DiVincenzo C, "The allelic spectrum of Charcot-Marie-Tooth disease in over 17, 000 individuals with neuropathy", Mol Genet Genomic Med, 2, pp.522~529 (2014)
29. Yoshimura A, "Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan", J Neurol Neurosurg Psychiatry, 90, pp.195~202 (2019)
30. Pakhrin PS, "Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations", J Neurol, 265, pp.637~646 (2018)
31. Gess B, "Charcot-Marie-Tooth disease : frequency of genetic subtypes in a German neuromuscular center population", Neuromuscul Disord, 23, pp.647~651 (2013)
32. Sivera R, "Charcot-Marie-Tooth disease : genetic and clinical spectrum in a Spanish clinical series", Neurology, 81, pp.1617~1625 (2013)
33. Sadjadi R, "Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score(CMTNSv2)second version, using Rasch analysis", J Peripher Nerv Syst, 19, pp.192~196 (2014)
34. Kim HJ, "Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations", Mol Genet Genomic Med, 9, pp.e1678~ (2021)
35. Fridman V, "CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study : a cross-sectional analysis", J Neurol Neurosurg Psychiatry, 86, pp.873~878 (2015)
36. Milley GM, "Genotypic and phenotypic spectrum of the most common causative genes of Charcot-Marie-Tooth disease in Hungarian patients", Neuromuscul Disord, 28, pp.38~43 (2018)
37. Østern R, "Diagnostic laboratory testing for Charcot Marie Tooth disease(CMT) : the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies", BMC Med Genet, 14, pp.94~ (2013)
38. Silander K, "Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies", Hum Mutat, 12, pp.59~68 (1998)
39. Miltenberger-Miltenyi G, "Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations", Eur J Hum Genet, 17, pp.1154~1159 (2009)
40. 김현수, "Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations", Journal of Clinical Neurology, 17(1), pp.52~62 (2021), 대한신경과학회
41. Kim HJ, "Phenotypic heterogeneity in patients with NEFL-related Charcot-Marie-Tooth disease", Mol Genet Genomic Med, 10, pp.e1870~ (2022)
42. Rudnik-Schöneborn S, "Diagnostic algorithms in Charcot-Marie-Tooth neuropathies : experiences from a German genetic laboratory on the basis of 1206 index patients", Clin Genet, 89, pp.34~43 (2016)
43. Saporta AS, "Charcot-Marie-Tooth disease subtypes and genetic testing strategies", Ann Neurol, 69, pp.22~33 (2011)
44. Manganelli F, "Charcot-Marie-Tooth disease : frequency of genetic subtypes in a Southern Italy population", J Peripher Nerv Syst, 19, pp.292~298 (2014)
45. Birouk N, "X-linked Charcot-Marie-Tooth disease with connexin 32 mutations : clinical and electrophysiologic study", Neurology, 50, pp.1074~1082 (1998)

관련 논문AI추천